AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma

Academic Article

Publication Date:

2016

Short description:

AVAREG: A phase II, randomized, noncomparative study of fotemustine or bevacizumab for patients with recurrent glioblastoma / Brandes, ., A., A., Finocchiaro, ., Zagonel, ., Reni, M., Caserta, ., Fabi, ., Clavarezza, ., Maiello, ., Eoli, ., Lombardi, ., Monteforte, ., Proietti, ., Agati, ., Eusebi, ., Franceschi,. - In: NEURO-ONCOLOGY. - ISSN 1522-8517. - (2016).

Iris type:

1.1 Articolo in rivista

List of contributors:

Brandes, ; A., A.; Finocchiaro, ; Zagonel, ; Reni, M; Caserta, ; Fabi, ; Clavarezza, ; Maiello, ; Eoli, ; Lombardi, ; Monteforte, ; Proietti, ; Agati, ; Eusebi, ; Franceschi,

Authors of the University:

RENI MICHELE

Handle:

https://iris.unisr.it/handle/20.500.11768/123801

Published in:

NEURO-ONCOLOGY

Journal